sounds like your disgruntled to me, that NWBO didnt meet YOUR self-imposed timeline, not that of the Company. Sorry you feel this way.
The worst mistake that retail biotech investors are guilty of, is selling at the exact wrong time.
I could care less if DCAX read-out happens in Q1 or Q2. In the end, 3 months will not make much of a difference, if at all.
I personally think NWBO will surprise some people. But as always, time will tell.
-Fireman